External Evaluation of Population Pharmacokinetic Models of Vancomycin in Large Cohorts of Intensive Care Unit Patients-Reference-Cited by-同舟云学术

External Evaluation of Population Pharmacokinetic Models of Vancomycin in Large Cohorts of Intensive Care Unit Patients

Published:2019-05 Issue:5 Volume:63 Page:
ISSN:0066-4804
Container-title:Antimicrobial Agents and Chemotherapy
language:en
Short-container-title:Antimicrob Agents Chemother

Author:

Guo Tingjie¹²,van Hest Reinier M.²,Roggeveen Luca F.¹,Fleuren Lucas M.¹,Thoral Patrick J.¹,Bosman Rob J.³,van der Voort Peter H. J.³,Girbes Armand R. J.¹,Mathot Ron A. A.²,Elbers Paul W. G.¹

Affiliation:

1. Department of Intensive Care Medicine, Amsterdam UMC, Location VUmc, Vrije Universiteit Amsterdam, Amsterdam Medical Data Science (AMDS), Research VUmc Intensive Care (REVIVE), Amsterdam Cardiovascular Sciences (ACS), Amsterdam, The Netherlands

2. Department of Pharmacy, Amsterdam UMC, Location AMC, University of Amsterdam, Amsterdam, The Netherlands

3. Intensive Care Unit, OLVG Oost, Amsterdam, The Netherlands

Abstract

Dosing of vancomycin is often guided by therapeutic drug monitoring and population pharmacokinetic models in the intensive care unit (ICU). The validity of these models is crucial, as ICU patients have marked pharmacokinetic variability.

Funder

ZonMw

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

Link

https://journals.asm.org/doi/pdf/10.1128/AAC.02543-18

Reference29 articles.

1. Therapeutic monitoring of vancomycin in adult patients: A consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists

2. Vancomycin: A History

3. Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children